Archive · Ars Technica
The FDA wants to pull its approval of a drug. It’s not so easy.
The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?
ZAZTEK archives the headline, summary and publication date so the story stays findable. The full article remains the publisher's. Read it at Ars Technica →